IgG4相关眼病三例报告
三例男性IgG4相关眼病患者均双眼受累并伴眶外组织受累,表现为泪腺肿大伴球结膜水肿或眼睑肿胀。经糖皮质激素冲击治疗后症状均好转,随访58至60个月,其中2例复发1次、1例复发3次。
要点
- 三例均为男性,双眼受累且伴眶外组织受累,诊断为IgG4相关眼病。
- 糖皮质激素冲击治疗后三例症状均好转。
- 随访58至60个月,2例复发1次、1例复发3次。
核心结论
- 三例男性IgG4相关眼病患者经糖皮质激素冲击治疗后症状均好转,但随访期间均出现复发。
研究设计与样本
- 三例病例报告,来源为中华眼科杂志2021年57卷375至378页。
主要发现
- 三例均为男性,眼部检查均为双眼受累。
- 2例表现为双眼泪腺肿大伴有球结膜水肿,1例为双眼眼睑肿胀。
- 三例均伴有眶外组织受累,均诊断为IgG4相关眼病。
- 经糖皮质激素冲击治疗后患者症状均好转,分别随访58、54、60个月。
- 随访期间2例患者复发1次,1例患者复发3次。
临床怎么用
- 对双眼受累并伴眶外组织受累的男性患者,应考虑IgG4相关眼病的诊断。
- 糖皮质激素冲击治疗可改善IgG4相关眼病症状,但需长期随访监测复发。
局限性
- 仅为三例病例报告,样本量小,无法提供疗效或复发的群体层面估计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The first patient complained visual loss of left eye for 1 week. The second patient complained visual loss of right eye for 2 months with conjunctival edema for more than 10 days. The third patient complained redness and swelling of both eyes for 1 year, poor appetite and fatigue for 4 months. All three patients were male with binocular involvement. Enlargement of lacrimal glands in both eyes with bulbar conjunctival edema were observed in 2 patients and binocular eyelid swelling in 1 patient, all 3 patients were associated with external orbital tissue involvement, which were diagnosed as IgG4-related ophthalmic diseases. After treatment with glucocorticoid, the symptoms of the patients were improved, and the patients were followed up for 58, 54, and 60 months, respectively. Among the 3 patients, 2 had recurrence for once, and 1 had recurrence 3 for times. (Chin J Ophthalmol, 2021, 57: 375-378). 1例主诉为左眼视力下降1周;1例主诉为右眼视力减退2个月、结膜水肿10余天;1例主诉为双眼红肿1年,纳差、乏力4个月患者分别就诊眼科。3例患者均为男性,眼部检查均为双眼受累,2例表现为双眼泪腺肿大伴有球结膜水肿,1例为双眼眼睑肿胀,3例均伴有眶外组织受累,均诊断为IgG4相关眼病。经糖皮质激素冲击治疗后患者症状均好转,分别随访58、54、60个月,其中2例患者复发1次,1例患者复发3次。(中华眼科杂志,2021,57:375-378).
引用
- Cao SS, Zhou HF, Wei SH, et al. [IgG4-related ophthalmic disease: three-case report]. Zhonghua Yan Ke Za Zhi. 2021. PMID: 33915642. doi:10.3760/cma.j.cn112142-20200917-00599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。